Chinanews.com, December 26, according to the website of the Beijing Stock Exchange, the 85th review meeting of the Listing Committee of the Beijing Stock Exchange in 2022 will be held on the morning of December 23, 2022.
The results of the review show that Beijing Kangleguard Biotechnology Co., Ltd. and Lierda Technology Group Co., Ltd. meet the issuance conditions, listing conditions and information disclosure requirements.
According to media reports, KangleGuard is the first company to pass the fourth set of standards of "market value + R&D investment" since the opening of the Beijing Stock Exchange. Its proposed fundraising amount reaches 2.38 billion yuan. The largest IPO on the exchange.
(China New Finance and Economics)
The picture is from the website of Beijing Stock Exchange
search
copy